Cargando…
Fungal Drug Response and Antimicrobial Resistance
Antifungal resistance is a growing concern as it poses a significant threat to public health. Fungal infections are a significant cause of morbidity and mortality, especially in immunocompromised individuals. The limited number of antifungal agents and the emergence of resistance have led to a criti...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219139/ https://www.ncbi.nlm.nih.gov/pubmed/37233275 http://dx.doi.org/10.3390/jof9050565 |
_version_ | 1785048938130178048 |
---|---|
author | Osset-Trénor, Paloma Pascual-Ahuir, Amparo Proft, Markus |
author_facet | Osset-Trénor, Paloma Pascual-Ahuir, Amparo Proft, Markus |
author_sort | Osset-Trénor, Paloma |
collection | PubMed |
description | Antifungal resistance is a growing concern as it poses a significant threat to public health. Fungal infections are a significant cause of morbidity and mortality, especially in immunocompromised individuals. The limited number of antifungal agents and the emergence of resistance have led to a critical need to understand the mechanisms of antifungal drug resistance. This review provides an overview of the importance of antifungal resistance, the classes of antifungal agents, and their mode of action. It highlights the molecular mechanisms of antifungal drug resistance, including alterations in drug modification, activation, and availability. In addition, the review discusses the response to drugs via the regulation of multidrug efflux systems and antifungal drug–target interactions. We emphasize the importance of understanding the molecular mechanisms of antifungal drug resistance to develop effective strategies to combat the emergence of resistance and highlight the need for continued research to identify new targets for antifungal drug development and explore alternative therapeutic options to overcome resistance. Overall, an understanding of antifungal drug resistance and its mechanisms will be indispensable for the field of antifungal drug development and clinical management of fungal infections. |
format | Online Article Text |
id | pubmed-10219139 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102191392023-05-27 Fungal Drug Response and Antimicrobial Resistance Osset-Trénor, Paloma Pascual-Ahuir, Amparo Proft, Markus J Fungi (Basel) Review Antifungal resistance is a growing concern as it poses a significant threat to public health. Fungal infections are a significant cause of morbidity and mortality, especially in immunocompromised individuals. The limited number of antifungal agents and the emergence of resistance have led to a critical need to understand the mechanisms of antifungal drug resistance. This review provides an overview of the importance of antifungal resistance, the classes of antifungal agents, and their mode of action. It highlights the molecular mechanisms of antifungal drug resistance, including alterations in drug modification, activation, and availability. In addition, the review discusses the response to drugs via the regulation of multidrug efflux systems and antifungal drug–target interactions. We emphasize the importance of understanding the molecular mechanisms of antifungal drug resistance to develop effective strategies to combat the emergence of resistance and highlight the need for continued research to identify new targets for antifungal drug development and explore alternative therapeutic options to overcome resistance. Overall, an understanding of antifungal drug resistance and its mechanisms will be indispensable for the field of antifungal drug development and clinical management of fungal infections. MDPI 2023-05-12 /pmc/articles/PMC10219139/ /pubmed/37233275 http://dx.doi.org/10.3390/jof9050565 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Osset-Trénor, Paloma Pascual-Ahuir, Amparo Proft, Markus Fungal Drug Response and Antimicrobial Resistance |
title | Fungal Drug Response and Antimicrobial Resistance |
title_full | Fungal Drug Response and Antimicrobial Resistance |
title_fullStr | Fungal Drug Response and Antimicrobial Resistance |
title_full_unstemmed | Fungal Drug Response and Antimicrobial Resistance |
title_short | Fungal Drug Response and Antimicrobial Resistance |
title_sort | fungal drug response and antimicrobial resistance |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219139/ https://www.ncbi.nlm.nih.gov/pubmed/37233275 http://dx.doi.org/10.3390/jof9050565 |
work_keys_str_mv | AT ossettrenorpaloma fungaldrugresponseandantimicrobialresistance AT pascualahuiramparo fungaldrugresponseandantimicrobialresistance AT proftmarkus fungaldrugresponseandantimicrobialresistance |